MYO Insider Transactions
| Transaction Date (SEC Report ) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price() | Amount() |
|---|---|---|---|---|---|---|---|---|
| 2023-03-08 | Kovelman Harry | officer: Chief Medical Officer | 67,317 | A-Award | A | 17,000 | 0.00 | 0.00 |
| 2023-03-08 | Mitchell Micah | officer: Chief Commerical Officer | 81,815 | A-Award | A | 17,000 | 0.00 | 0.00 |
| 2023-03-08 | HENRY DAVID A | officer: Chief Financial Officer | 180,527 | A-Award | A | 17,000 | 0.00 | 0.00 |
| 2023-03-08 | GUDONIS PAUL R | director, officer: Chief Executive Officer | 500,345 | A-Award | A | 17,000 | 0.00 | 0.00 |
| 2023-03-03 | Kovelman Harry | officer: Chief Medical Officer | 50,317 | F-InKind | D | 130 | 0.62 | 80.60 |
| 2023-02-03 | Kovelman Harry | officer: Chief Medical Officer | 50,447 | F-InKind | D | 132 | 0.49 | 64.68 |
| 2023-01-17 | Mitchell Micah | officer: Chief Commerical Officer | 64,815 | P-Purchase | A | 15,384 | 0.33 | 4,999.80 |
| 2023-01-17 | GUDONIS PAUL R | director, officer: Chief Executive Officer | 483,345 | P-Purchase | A | 307,692 | 0.33 | 99,999.90 |
| 2023-01-17 | HENRY DAVID A | officer: Chief Financial Officer | 163,527 | P-Purchase | A | 76,923 | 0.33 | 24,999.98 |
| 2023-01-04 | Kovelman Harry | officer: Chief Medical Officer | 50,579 | F-InKind | D | 139 | 0.49 | 68.11 |
| 2022-12-05 | Kovelman Harry | officer: Chief Medical Officer | 50,718 | F-InKind | D | 126 | 0.66 | 83.16 |
| 2022-12-01 | KIRK THOMAS F | director | 0 | X-InTheMoney | D | 333 | 0.00 | 0.03 |
| 2022-12-01 | KIRK THOMAS F | director | 26,513 | X-InTheMoney | A | 333 | 0.00 | 0.03 |
| 2022-11-22 | HENRY DAVID A | officer: Chief Financial Officer | 86,604 | P-Purchase | A | 9,000 | 0.55 | 4,959.90 |
| 2022-11-21 | GUDONIS PAUL R | director, officer: Chief Executive Officer | 0 | X-InTheMoney | D | 333 | 0.00 | 0.03 |
| 2022-11-21 | GUDONIS PAUL R | director, officer: Chief Executive Officer | 175,653 | X-InTheMoney | A | 333 | 0.00 | 0.03 |
| 2022-11-03 | Kovelman Harry | officer: Chief Medical Officer | 50,844 | F-InKind | D | 125 | 1.37 | 171.25 |
| 2022-10-03 | Kovelman Harry | officer: Chief Medical Officer | 50,969 | F-InKind | D | 128 | 1.57 | 200.96 |
| 2022-09-06 | Kovelman Harry | officer: Chief Medical Officer | 51,097 | F-InKind | D | 128 | 1.76 | 225.28 |
| 2022-08-05 | Crowley Thomas Aloysius Jr. | director | 12,901 | S-Sale | D | 7,141 | 1.71 | 12,218.25 |
| 2022-08-03 | Kovelman Harry | officer: Chief Medical Officer | 51,225 | F-InKind | D | 118 | 1.91 | 225.55 |
| 2022-07-05 | Kovelman Harry | officer: Chief Medical Officer | 51,343 | F-InKind | D | 127 | 1.64 | 208.28 |
| 2022-06-13 | Kovelman Harry | officer: Chief Medical Officer | 51,470 | F-InKind | D | 484 | 1.83 | 885.72 |
| 2022-06-13 | Mitchell Micah | officer: Chief Commerical Officer | 49,431 | F-InKind | D | 1,846 | 1.79 | 3,311.72 |
| 2022-06-13 | HENRY DAVID A | officer: Chief Financial Officer | 77,604 | F-InKind | D | 4,417 | 1.80 | 7,932.93 |
| 2022-06-08 | Mitchell Micah | officer: Chief Commerical Officer | 51,277 | A-Award | A | 28,000 | 0.00 | 0.00 |
| 2022-06-08 | Kovelman Harry | officer: Chief Medical Officer | 51,954 | A-Award | A | 28,000 | 0.00 | 0.00 |
| 2022-06-08 | HENRY DAVID A | officer: Chief Financial Officer | 82,021 | A-Award | A | 41,500 | 0.00 | 0.00 |
| 2022-06-08 | GUDONIS PAUL R | director, officer: Chief Executive Officer | 175,320 | A-Award | A | 75,000 | 0.00 | 0.00 |
| 2022-06-03 | Kovelman Harry | officer: Chief Medical Officer | 23,954 | F-InKind | D | 138 | 2.31 | 318.78 |
| 2022-05-24 | Kovelman Harry | officer: Chief Medical Officer | 24,092 | F-InKind | D | 2,849 | 2.06 | 5,868.94 |
| 2022-05-24 | HENRY DAVID A | officer: Chief Financial Officer | 40,521 | F-InKind | D | 3,394 | 2.06 | 6,991.64 |
| 2022-05-20 | Mitchell Micah | officer: Chief Commerical Officer | 23,277 | A-Award | A | 7,424 | 0.00 | 0.00 |
| 2022-05-20 | Kovelman Harry | officer: Chief Medical Officer | 26,941 | A-Award | A | 6,987 | 0.00 | 0.00 |
| 2022-05-20 | HENRY DAVID A | officer: Chief Financial Officer | 43,915 | A-Award | A | 8,297 | 0.00 | 0.00 |
| 2022-05-20 | GUDONIS PAUL R | director, officer: Chief Executive Officer | 100,320 | A-Award | A | 8,302 | 0.00 | 0.00 |
| 2022-05-03 | Kovelman Harry | officer: Chief Medical Officer | 19,954 | F-InKind | D | 134 | 3.03 | 406.02 |
| 2022-04-04 | Kovelman Harry | officer: Chief Medical Officer | 20,088 | F-InKind | D | 134 | 4.01 | 537.34 |
| 2022-03-14 | GUDONIS PAUL R | director, officer: Chief Executive Officer | 92,018 | P-Purchase | A | 5,000 | 4.22 | 21,085.00 |
| 2022-03-11 | GUDONIS PAUL R | director, officer: Chief Executive Officer | 87,018 | P-Purchase | A | 5,000 | 4.63 | 23,145.50 |
| 2022-03-07 | Kovelman Harry | officer: Chief Medical Officer | 20,222 | F-InKind | D | 131 | 7.22 | 945.82 |
| 2022-02-03 | Kovelman Harry | officer: Chief Medical Officer | 20,353 | F-InKind | D | 132 | 7.60 | 1,003.20 |
| 2022-01-03 | Kovelman Harry | officer: Chief Medical Officer | 20,485 | F-InKind | D | 125 | 7.22 | 902.50 |
| 2021-12-03 | Kovelman Harry | officer: Chief Medical Officer | 20,610 | F-InKind | D | 128 | 7.75 | 992.00 |
| 2021-11-16 | HENRY DAVID A | officer: Chief Financial Officer | 35,618 | P-Purchase | A | 1,000 | 8.86 | 8,855.00 |
| 2021-11-12 | GUDONIS PAUL R | director, officer: Chief Executive Officer | 82,018 | P-Purchase | A | 1,000 | 9.86 | 9,857.70 |
| 2021-11-03 | Kovelman Harry | officer: Chief Medical Officer | 20,738 | F-InKind | D | 1,625 | 10.39 | 16,883.75 |
| 2021-11-02 | Crowley Thomas Aloysius Jr. | director | 0 | M-Exempt | D | 208 | 0.05 | 9.98 |
| 2021-11-02 | Crowley Thomas Aloysius Jr. | director | 19,831 | M-Exempt | A | 208 | 0.05 | 9.98 |
| 2021-11-02 | Crowley Thomas Aloysius Jr. | director | 20,042 | M-Exempt | A | 211 | 0.05 | 10.13 |
| 2021-07-21 | Mitchell Micah | officer: Chief Commerical Officer | 15,853 | S-Sale | D | 1,385 | 0.00 | 0.00 |
| 2021-07-20 | Mitchell Micah | officer: Chief Commerical Officer | 17,238 | S-Sale | D | 5,745 | 0.00 | 0.00 |
| 2021-06-11 | HENRY DAVID A | officer: Chief Financial Officer | 34,618 | F-InKind | D | 4,548 | 0.00 | 0.00 |
| 2021-06-11 | Mitchell Micah | officer: Chief Commerical Officer | 22,982 | F-InKind | D | 2,133 | 0.00 | 0.00 |
| 2021-06-11 | CONNEIGHTON CLIFF | officer: Chief Marketing Officer | 17,738 | F-InKind | D | 2,083 | 0.00 | 0.00 |
| 2021-06-10 | Mitchell Micah | officer: Chief Commerical Officer | 25,115 | F-InKind | D | 154 | 11.51 | 1,772.54 |
| 2021-06-10 | CONNEIGHTON CLIFF | officer: Chief Marketing Officer | 19,821 | F-InKind | D | 208 | 11.51 | 2,394.08 |
| 2021-06-10 | Crowley Thomas Aloysius Jr. | director | 520 | M-Exempt | D | 211 | 0.05 | 10.13 |
| 2021-06-10 | Crowley Thomas Aloysius Jr. | director | 20,042 | M-Exempt | A | 419 | 0.05 | 20.11 |
| 2021-06-10 | Crowley Thomas Aloysius Jr. | director | 312 | M-Exempt | D | 208 | 0.00 | 0.00 |
| 2021-06-09 | KIRK THOMAS F | director | 26,180 | A-Award | A | 2,945 | 0.00 | 0.00 |
| 2021-06-09 | Knapp Amy K. | director | 19,623 | A-Award | A | 2,945 | 0.00 | 0.00 |
| 2021-06-09 | Morris Milton Mayo | director | 2,945 | A-Award | A | 2,945 | 0.00 | 0.00 |
| 2021-06-09 | Crowley Thomas Aloysius Jr. | director | 19,623 | A-Award | A | 2,945 | 0.00 | 0.00 |
| 2021-06-09 | Kovelman Harry | officer: Chief Medical Officer | 22,363 | A-Award | A | 4,100 | 0.00 | 0.00 |
| 2021-06-09 | Kovelman Harry | officer: Chief Medical Officer | 8,200 | A-Award | A | 8,200 | 0.00 | 0.00 |
| 2021-06-09 | GUDONIS PAUL R | officer: Chief Executive Officer | 81,018 | A-Award | A | 20,000 | 0.00 | 0.00 |
| 2021-06-09 | GUDONIS PAUL R | officer: Chief Executive Officer | 40,000 | A-Award | A | 40,000 | 0.00 | 0.00 |
| 2021-06-09 | HENRY DAVID A | officer: Chief Financial Officer | 39,166 | A-Award | A | 10,000 | 0.00 | 0.00 |
| 2021-06-09 | HENRY DAVID A | officer: Chief Financial Officer | 20,000 | A-Award | A | 20,000 | 0.00 | 0.00 |
| 2021-06-09 | Mitchell Micah | officer: Chief Commerical Officer | 11,400 | A-Award | A | 11,400 | 0.00 | 0.00 |
| 2021-06-09 | Mitchell Micah | officer: Chief Commerical Officer | 25,269 | A-Award | A | 5,700 | 0.00 | 0.00 |
| 2020-07-01 | CONNEIGHTON CLIFF | officer: Chief Marketing Officer | 20,029 | A-Award | A | 17,500 | 0.00 | 0.00 |
| 2020-07-01 | Knapp Amy K. | director | 16,678 | A-Award | A | 15,110 | 0.00 | 0.00 |
| 2020-07-01 | GUDONIS PAUL R | officer: Chief Executive Officer | 61,133 | A-Award | A | 35,000 | 0.00 | 0.00 |
| 2020-07-01 | Crowley Thomas Aloysius Jr. | director | 16,678 | A-Award | A | 15,110 | 0.00 | 0.00 |
| 2020-07-01 | HENRY DAVID A | officer: Chief Financial Officer | 29,166 | A-Award | A | 25,000 | 0.00 | 0.00 |
| 2020-07-01 | Naft Jonathan | officer: VP, General Manager | 22,298 | A-Award | A | 17,500 | 0.00 | 0.00 |
| 2020-07-01 | KIRK THOMAS F | director | 23,235 | A-Award | A | 15,110 | 0.00 | 0.00 |
| 2020-07-01 | Mitchell Micah | officer: Chief Commerical Officer | 19,569 | A-Award | A | 17,500 | 0.00 | 0.00 |
| 2020-06-05 | Green Brandon M | officer: Chief Medical Officer | 1,664 | F-InKind | D | 292 | 0.00 | 0.00 |
| 2020-06-05 | CONNEIGHTON CLIFF | officer: Chief Marketing Officer | 2,529 | F-InKind | D | 198 | 3.79 | 750.42 |
| 2020-02-13 | HENRY DAVID A | officer: Chief Financial Officer | 3,500 | P-Purchase | A | 3,500 | 7.50 | 26,250.00 |
| 2020-02-13 | HENRY DAVID A | officer: Chief Financial Officer | 4,166 | P-Purchase | A | 3,500 | 7.50 | 26,250.00 |
| 2020-02-13 | KIRK THOMAS F | director | 6,000 | P-Purchase | A | 3,500 | 7.50 | 26,250.00 |
| 2020-02-13 | KIRK THOMAS F | director | 8,125 | P-Purchase | A | 3,500 | 7.50 | 26,250.00 |
| 2020-02-13 | GUDONIS PAUL R | officer: Chief Executive Officer | 20,133 | A-Award | A | 1,333 | 0.00 | 0.00 |
| 2020-02-13 | GUDONIS PAUL R | officer: Chief Executive Officer | 26,133 | P-Purchase | A | 6,000 | 7.50 | 45,000.00 |
| 2020-02-13 | GUDONIS PAUL R | officer: Chief Executive Officer | 6,000 | P-Purchase | A | 6,000 | 7.50 | 45,000.00 |
| 2019-12-16 | GUDONIS PAUL R | officer: Chief Executive Officer | 18,800 | A-Award | A | 1,333 | 0.00 | 0.00 |
| 2019-10-22 | GUDONIS PAUL R | officer: Chief Executive Officer | 524,017 | A-Award | A | 40,000 | 0.00 | 0.00 |
| 2019-10-11 | SANGHI STEVE | director | 570,621 | D-Return | D | 25,006 | 0.00 | 0.00 |
| 2019-09-30 | GUDONIS PAUL R | officer: Chief Executive Officer | 484,017 | F-InKind | D | 838 | 0.00 | 0.00 |
| 2019-07-09 | Mitchell Micah | officer: Chief Commerical Officer | 62,093 | F-InKind | D | 1,760 | 0.00 | 0.00 |
| 2019-06-30 | GUDONIS PAUL R | officer: Chief Executive Officer | 484,855 | F-InKind | D | 802 | 0.00 | 0.00 |
| 2019-06-05 | Naft Jonathan | officer: VP, General Manager | 143,984 | A-Award | A | 50,000 | 0.00 | 0.00 |
| 2019-06-05 | Crowley Thomas Aloysius Jr. | director | 47,114 | A-Award | A | 33,341 | 0.00 | 0.00 |
| 2019-06-05 | Knapp Amy K. | director | 47,114 | A-Award | A | 33,341 | 0.00 | 0.00 |
| 2019-06-05 | Mitchell Micah | officer: Chief Commerical Officer | 63,853 | A-Award | A | 40,000 | 0.00 | 0.00 |
| 2019-06-05 | Green Brandon M | officer: Chief Medical Officer | 58,751 | A-Award | A | 50,000 | 0.00 | 0.00 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Group doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Group or anyone involved with Discounting Cash Flows Group will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.